UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 407

Sortiert nach

Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants

Journal of clinical oncology, 1998-09, Vol.16 (9), p.3028-3036

1998

Volltextzugriff (PDF)

5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma

Bone marrow transplantation (Basingstoke), 2013-05, Vol.48 (5), p.642-645

2013

Volltextzugriff (PDF)

How Effective Is Dose-Intensive/Myeloablative Therapy Against Ewing’s Sarcoma/Primitive Neuroectodermal Tumor Metastatic to Bone or Bone Marrow? The Memorial Sloan-Kettering Experience and a Literature Review

Journal of clinical oncology, 2001-02, Vol.19 (3), p.870-880

2001

Volltextzugriff (PDF)

Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy

Journal of clinical oncology, 1996-05, Vol.14 (5), p.1526-1531

1996

Volltextzugriff (PDF)

Extending Positron Emission Tomography Scan Utility to High-Risk Neuroblastoma: Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography as Sole Imaging Modality in Follow-Up of Patients

Journal of clinical oncology, 2001-07, Vol.19 (14), p.3397-3405

2001

Volltextzugriff (PDF)

Hyperfractionated Low-Dose Radiotherapy for High-Risk Neuroblastoma After Intensive Chemotherapy and Surgery

Journal of clinical oncology, 2001-06, Vol.19 (11), p.2821-2828

2001

Volltextzugriff (PDF)

Topotecan, thiotepa, and carboplatin for neuroblastoma: failure to prevent relapse in the central nervous system

Bone marrow transplantation (Basingstoke), 2006-02, Vol.37 (3), p.271-276

2006

Volltextzugriff (PDF)

Optimal Repeated Measurements Designs: The Linear Optimality Equations

The Annals of statistics, 1997-12, Vol.25 (6), p.2328-2344

Kushner, H. B.

1997

Volltextzugriff (PDF)

Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review

Journal of clinical oncology, 1998-12, Vol.16 (12), p.3880-3889

1998

Volltextzugriff (PDF)

Optimal and Efficient Repeated-Measurements Designs for Uncorrelated Observations

Journal of the American Statistical Association, 1998-09, Vol.93 (443), p.1176-1187

Kushner, H. B.

1998

Volltextzugriff (PDF)

Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age

Journal of clinical oncology, 1994-12, Vol.12 (12), p.2607-2613

1994

Volltextzugriff (PDF)

Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?

Journal of clinical oncology, 1997-08, Vol.15 (8), p.2807-2817

1997

Volltextzugriff (PDF)

High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors

Journal of clinical oncology, 1998-09, Vol.16 (9), p.3016-3020

1998

Volltextzugriff (PDF)

Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults

Journal of clinical oncology, 1995-11, Vol.13 (11), p.2796-2804

1995

Volltextzugriff (PDF)

Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma

Journal of clinical oncology, 2001-11, Vol.19 (22), p.4189-4194

2001

Volltextzugriff (PDF)

Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy

Journal of clinical oncology, 1996-02, Vol.14 (2), p.373-381

1996

Volltextzugriff (PDF)

Local control with multimodality therapy for Stage 4 neuroblastoma

International journal of radiation oncology, biology, physics, 2000-03, Vol.46 (4), p.969-974

2000

Volltextzugriff (PDF)

GM-CSF Enhances 3F8 Monoclonal Antibody-Dependent Cellular Cytotoxicity Against Human Melanoma and Neuroblastoma

Blood, 1989-05, Vol.73 (7), p.1936-1941

1989

Volltextzugriff (PDF)

Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults

Bone marrow transplantation (Basingstoke), 2001-09, Vol.28 (6), p.551-556

2001

Volltextzugriff (PDF)

Oral Etoposide for Refractory and Relapsed Neuroblastoma

Journal of clinical oncology, 1999-10, Vol.17 (10), p.3221-3225

1999

Volltextzugriff (PDF)

3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study

International journal of oncology, 1998-06, Vol.12 (6), p.1299

1998

Volltextzugriff (PDF)

Absolute requirement of CD11/CD18 adhesion molecules, FcRII, and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytotoxicity

Blood, 1992-03, Vol.79 (6), p.1484-1490

1992

Volltextzugriff (PDF)

Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma

Clinical cancer research, 1998-09, Vol.4 (9), p.2135-2139

1998

Volltextzugriff (PDF)

Allocation rules for adaptive repeated measurements designs

Journal of statistical planning and inference, 2003-04, Vol.113 (1), p.293-313

Kushner, H.B.

2003

Volltextzugriff (PDF)

International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review

Journal of clinical oncology, 1996-07, Vol.14 (7), p.2174-2180

1996

Volltextzugriff (PDF)

1 – 25 von 407

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(361)
Mit Volltextzugriff
(347)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(278)
Humans
(264)
Life Sciences & Biomedicine
(249)
Female
(146)
Biological And Medical Sciences
(135)
Male
(127)
Medical Sciences
(125)
Adult
(91)
Child
(86)
Oncology
(82)
Adolescent
(71)
Child, Preschool
(64)
Infant
(56)
Pharmacology. Drug Treatments
(38)
Pediatrics
(36)
Neuroblastoma - Therapy
(34)
Middle Aged
(33)
Neuroblastoma - Pathology
(33)
Treatment Outcome
(33)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants

5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma

How Effective Is Dose-Intensive/Myeloablative Therapy Against Ewing’s Sarcoma/Primitive Neuroectodermal Tumor Metastatic to Bone or Bone Marrow? The Memorial Sloan-Kettering Experience and a Literature Review

Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy

Extending Positron Emission Tomography Scan Utility to High-Risk Neuroblastoma: Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography as Sole Imaging Modality in Follow-Up of Patients

Hyperfractionated Low-Dose Radiotherapy for High-Risk Neuroblastoma After Intensive Chemotherapy and Surgery

Topotecan, thiotepa, and carboplatin for neuroblastoma: failure to prevent relapse in the central nervous system

Optimal Repeated Measurements Designs: The Linear Optimality Equations

Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review

Optimal and Efficient Repeated-Measurements Designs for Uncorrelated Observations

Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age

Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?

High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors

Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults

Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma

Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy

Local control with multimodality therapy for Stage 4 neuroblastoma

GM-CSF Enhances 3F8 Monoclonal Antibody-Dependent Cellular Cytotoxicity Against Human Melanoma and Neuroblastoma

Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults

Oral Etoposide for Refractory and Relapsed Neuroblastoma

3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study

Absolute requirement of CD11/CD18 adhesion molecules, FcRII, and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytotoxicity

Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma

Allocation rules for adaptive repeated measurements designs

International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review

Suchergebnisse filtern